Coating Additives Market Global Industry Analysis By Trends, Future Demands, Growth Factors 2028

 Global Coating Additives Industry: A Latest Research Report to Share Market Insights and Dynamics

The global coating additives market size is anticipated to reach $11.91 billion by 2026, growing at a CAGR of 4.8% during the forecast period, according to a report published by Polaris Market Research.  The report ‘Coating Additives Market By Product Type (Metallic, Acrylic, Urethane, Fluor polymer & Others), By Formulation (Solvent-Borne, Water-Borne and Powder-Based), By Function (Wetting & Dispersion, Anti-Foaming, Biocides, Rheology Modification and Others), By Application (Building & Construction, Automotive, Wood, Industrial and Others), By Regions & Segments Forecast, 2018 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends.

 

Rapidly growing demand of coating additives from numerous end-use industries is anticipated to be the major driver for the market. Coatings are complex and versatile solutions and are generally known for offering better challenges to formulators in comparison to any other product. Global coating additive market has changed substantially in the last decade and is likely to continue with the changes during the forecast period due to its highly competitive characteristics.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/coating-additives-market/request-for-sample

 

The essential constituents of coatings, the process of its composition and environmental-based parameters have mainly driven the innovation for this market. The regulatory framework backed up by environmental & health concerns include reduction or complete elimination of volatile organic compounds (VOC) or any other constituent that is known to be hazardous in nature.

  

The application sectors for coating additives have witnessed moderate growth, however, demand for novel and innovative additive compositions are anticipated to increase rapidly. Pressure due to environmental impact of these coating additives is considered to be a major driving parameter driving forces for advent of new types of coating additives. Also, significant focus has been levied upon the appearance effect d these additives coupled with the with the costs of its utilization. Stringent regulatory framework and changing consumer behaviour concerning the environment-friendly products have forced coating manufacturers to launch innovative and sustainable products.

 

New and highly complex environmental policies & regulations, introduced specifically to minimize the waste and support recycling & recovery of additives, have resulted in new additive technologies and their manufacturing techniques.

 

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Coating Additives Market, 2017-2026. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC and South America, and MEA. North America is further segmented into U.S., Canada. Europe is divided into Germany, UK, Italy, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific.

 

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/coating-additives-market/speak-to-analyst

 

Competitive Landscape and Key Vendors

The coating additives market is a fragmented with large number of international and domestic players. Asia Pacific was the largest coating additive regional market in 2017. This was mainly on account of rapid growth in the industrial production in tandem with the rapidly growing automobile and construction sector that have resulted in increased consumption of pants & coatings and their additives. Developing nations such as India apart from other countries such as China, Japan, and South Korea Apart from South Korea, has contributed significantly to the regional growth by becoming a major manufacturing hub of additives. European nations including France, Germany, Italy, and UK are likely to be some of the significant countries to produce considerable demand by 2026 in Europe. North America is yet another significantly growing coating additives market in terms of concerning increasing consumption and production.

 

Some of the major coating additives market players include Solvay, DSM, Lord Corporation, Jotun A/S, BASF SE, Eastman Chemical Company, Clariant AG, Cabot Corporation, Dynea as (Norway), Rhodia SA, Bayer AG,  Double Bond Chemical Ind., Co., Ltd., Valspar Corporation, ICL Advanced Additives, Kenrich Petrochemicals, Inc., Berger Paints, Nippon Paint, Beckers Group, Arkema SA, Kansai Paint, Sherwin-Williams Company, KCC Paint, PPG Industries, and Axalta Coating Systems.

 

Geriatric Medicines Market Analysis, Revenue, Price, Share, Growth Rate, Forecast to 2028

^{The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by Polaris Market Research.} 

 

^{Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.}

 

^{The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions.}

 

^{Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market/request-for-sample}

 

^{Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.}

  

^{The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography. On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.}

 

^{Speak to Analyst to know more @   https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market/speak-to-analyst}

 

 

^{North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.}

 

^{Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.}

Catheters Market Global Industry Analysis By Trends, Future Demands, Growth Factors 2028

 Global Catheters Industry: A Latest Research Report to Share Market Insights and Dynamics

According to a new report published by Polaris Market Research, the global catheters market is anticipated to reach USD 56.5 billion by 2025. In 2017, by product type, cardiovascular catheter segment captures the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the catheter market.

 

Catheters are thin tubes made up of plastic, nylon, polyvinyl chloride (PVC), and silicon rubber. Catheters are majorly used in catheterization while surgical procedures like angioplasty, and neurosurgery. The catheters market is primarily driven by continuous growth in the population suffering from cardiovascular disorders and diabetes. Presently, various countries showed the growth in number of patients suffering from hypertension and diabetes which is braced by factors such as smoking, drinking and sedentary lifestyle of the population. In addition, favorable reimbursement policies, increasing demand for minimal invasive surgeries, and technological advanced catheter with high effectiveness by its use would spur the global catheter market during the forecast period. on other hand, the wide application of catheter in various surgeries such as angioplasty would also push this market. The reimbursements by the Medicaid program that provide approximately 100 catheters per month to add the growth of catheter market in the future.

 

Get sample Copy: https://www.polarismarketresearch.com/industry-analysis/global-catheters-market/request-for-sample

 

Cardiovascular Catheters, holds a major share in the global catheter market. The cardiovascular catheter market is further segmented as PTCA balloon catheters, IVUS catheters, PTA balloon catheters, electrophysiological catheters, and others. The growth of cardiovascular catheters is majorly driven by the increasing incidences of cardiovascular diseases supporting the growth of cardiovascular interventional procedures. While, urological catheter holds the second largest segment with largest revenue. The factors contributing for the growth of urological market are continuous technological advancements, and increasing prevalence of urological diseases in the coming year.

 

Geographically, North America holds a dominating position in the global catheter market followed by Europe and Asia Pacific. The growth in the North America catheter market is driven by the presence of refined health infrastructure, high volume of catheterization in medical procedures, high healthcare expenditure by the individuals, and high level of patient awareness about the use catheters. Whereas, Asia Pacific is expected to reach remarkable growth owning to the increased penetration rate of these devices in the developing countries, growing technological advancements pertaining the development of new-catheter devices, and improving healthcare expenditure would influence the catheter market in Asia Pacific during the forecast period.

 

Do you have questions or special requirements? Ask our industry experts: https://www.polarismarketresearch.com/industry-analysis/global-catheters-market/speak-to-analyst

 

The leading companies operating in this industry include Johnson & Johnson Inc., Abbott Laboratories, Becton, Dickson and Company, B. Braun Melsungen AG., Medtronic plc., Boston Scientific Corporation, Cook Group Incorporated, Teleflex Incorporated, Cardinal Health Inc., Smiths Medical, Arrow International Inc., Edward Life Science Corporation, and Coloplast.

 

Key Findings from the study suggest products available in the market are continuously concentrating on the technological advancements that will reduce the side effects caused by the use of catheters. The leading companies while developing new products considers the factors such as increasing disposable income, and untapped market potential. North America is presumed to dominate the global catheter market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

 

Automotive Lubricants Market 2021 SWOT Analysis, Top Key Company Profiles and Latest Trends

 Global Automotive Lubricants Industry: The Latest Research Report to Share Market Insights and Dynamics

 

The global automotive lubricants market is anticipated to reach USD 75.63 billion by 2026 according to a new study published by Polaris Market Research. Increasing demand for high quality lubes from automobile manufacturers has created a surge in demand for these products. The economic, regulatory and political forces have reshaped the dynamics of the lubricants demand and supply throughout the globe. Opportunities for the industry participants to expand the business have continued to emerge significantly. The automotive lube segment has emerged as a major growth market, in addition to a source of competitively priced mechanism in the overall lubricant industry. Currently strong growth in the automotive manufacturing industry is creating several new market opportunities for these product manufacturers.

 

In the automobile industry, the consumers have been migrating for enhanced quality vehicles and the increase in demand for the four stroke motorbikes. Manufacturers of these products with significant tie ups with the OEMs that use lubricants of higher-grade quality, offering multi-grade lubricants with powerful brand recognition and wide range of distribution networks are expected to gain higher market share in the competitive industry space over the forecast period. Increased car and motorcycle stock, increase in agricultural machinery driven lubes consumption have been the primary factors to drive the automotive lubricants market.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/automotive-lubricants-market/request-for-sample

  

The multinationals players with superior technology, brand image and finances have retained the power to introduce themselves on their own in the industry. However, with the increasing number of companies it has been not a easy task for everyone to attain a carve a niche in the industry space. The sector has witnessed significant numbers of acquisitions and mergers. The most recent is the acquisition of Castrol by British Petroleum. Several recent deregulations in the automobile lubricant industry have promised numerous new opportunities especially for the private lubricant manufacturers operating in many foreign countries.

 

 The Asia Pacific Automotive Lubricants Market is expected to generate the highest demand for these products by 2026 with an increasing demand especially from the small four-wheeler segment. Increasing industrialization rate in the emerging economies such as India, Vietnam, Philippines, Malaysia, and Indonesia along with high demand from China, South Korea, Japan and Australia have added additional numbers to the yearly automobile manufacturing volume in the region. This is expected to be the major factor expected to drive demand for the products over till 2026 and beyond.

 

Do you have questions or special requirements? Ask our industry experts: https://www.polarismarketresearch.com/industry-analysis/automotive-lubricants-market/speak-to-analyst

 

The few of the leading automotive lubricants market participants currently operating in a worldwide scale include Valvoline, Arabol Lubricants, Total Oil, BP, Indian Oil Corporation, Phillips 66 Lubricants, Bel-Ray Company LLC., Amsoil (Wisconsin), Bharat Petroleum, Morris Lubricants, Ultrachem  Inc , Penrite Oil, Valvoline ,  Rock Valley Oil and Chemical Co., Peak Lubricants Pty Ltd , Lubrizol, Liqui Moly,  Eni S.P.A.  and Emulsichem Lubricants Pvt. Ltd.

 

Buy now : https://www.polarismarketresearch.com/checkouts/1121

Malaria Vaccines Market Recent Developments | Impact of Covid 19 Detailed Analysis

 The global malaria vaccines market is expected to reach USD 134.9 million by 2026 growing at a CAGR of 33.2% during the forecast period according to a new study published by Polaris Market Research. The report ‘Malaria Vaccines Market Size Report By Agent (Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species); By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine); By Channel of Distribution (Hospitals, Clinics, Community Centers); By Regions: Segment Forecast, 2019 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends.

 

According to the World Malaria Report published by WHO in November 2018, the cases for malaria were 219 million in 2017 in more than 90 countries which were up from 217 million cases in 2017. The total deaths due to malaria in 2017 were 435,000 which were registered in the malaria affected regions.

 

The market for malaria vaccines globally has been divided based on vaccine type, agent, channel of distribution and region. Considering the vaccine type, the market is bifurcated into pre-erythrocytic vaccine, erythrocytic vaccine, and multi-antigen vaccine. The channel of distribution used for malaria vaccines include the hospitals, clinics and community centers. Considering the agent used in the malaria vaccines, the global market is divided into plasmodium falciparum, anopheles species, and plasmodium vivax. Geographically, as per the WHO report, nearly half of the world’s population was at risk in 2017, wherein the African region was the most affected one. Along with Africa, Asia Pacific region is also expected to grow at a considerable rate among all the other regions with Middle-east and Latin America likely to be the other potential regions for malaria vaccines market. North America and Europe have lower cases of malaria related diseases with regions such as Africa monitoring some of the highest deaths of children related to malaria globally.

 

Download for sample copy @ https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/request-for-sample

 

Some of the major factors pushing the market include the expanding occurrences of malaria in addition to the existence of numerous companies that are introducing low profit margin vaccines throughout the world. Increasing awareness associated to the aftereffects of the disease, continuous R&D in this section and increased funding from the government of the developing and developed countries together is pushing the market for malaria vaccines globally. Weak supply chain and distribution network among some of the developing countries which are affected by malaria are creating restraints for the market growth in these regions, however companies and government organizations are working together to overcome this challenge. It is anticipated that the continuous R&D for malaria vaccines and the continuous growth of this disease will help the market to grow in the coming years.

 

A few key strategies adopted by companies operating in the malaria vaccines market are new technology and product development, and geographical expansion among the developing regions to focus on proving vaccines to the areas highly affected by the disease at lower cost. The leading players operating in the market globally are GlaxoSmithKline, GenVec, Inc., Nobelpharma, and Sanaria. Some other promising vendors are Cadila Healthcare Ltd., CellFree Sciences Co. Ltd., VLP Therapeutics LLC, and Genome ReS Ltd. among others.

 

Else Place Inquiry for Discount @ https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/request-for-discount-pricing

  

Polaris Market Research has segmented the global malaria vaccines market on the basis of source type, application and region:

 

Malaria Vaccines Agent Type Outlook (Revenue, USD Million, 2015 – 2026)

• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species

Malaria Vaccines Vaccine Type Outlook (Revenue, USD Million, 2015 – 2026)

• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-antigen Vaccine

Malaria Vaccines Distribution Channel Type Outlook (Revenue, USD Million, 2015 – 2026)

• Hospitals
• Clinics
• Community Centers

Malaria Vaccines Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America (U.S., Canada)
• Europe (Germany, UK, France, Italy, Spain)
• Asia-Pacific (China, Japan, India)
• Latin America (Brazil, Mexico)
• Middle East and Africa

Complex Fertilizers Market 2021 SWOT Analysis, Top Key Company Profiles and Latest Trends

 The global complex fertilizers market size is anticipated to reach USD 54.8 billion by 2026 according to a new research published by Polaris Market Research. The report “Complex Fertilizers Market Share, Size, Trends & Analysis Report, By Product (Complete, Incomplete); By Form (Solid, Liquid); By Crop (Cereals and Grains, Fruits and Vegetables, Oilseeds); By Regions Segment Forecast, 2019 – 2026” provides a complete analysis of present market trends and future insights.

 

Complex or compound fertilizers produced by union of two or more kinds of macronutrient fertilizers are used in a manner of providing crops the correct level of fertility. The complex fertilizers industry has expanded at a brisk pace in the past and continues to enjoy steady growth rate as factors such as rising industrialization, urbanization, rise in energy consumption and conversion of arable lands into commercial infrastructures and making a need for provision of proper fertility to tilled lands more immediate.

 

Farmers are being educated regarding use of proper fertilizers for that particular crop, and kind of pests most commonly affecting it and soil fertility has all got to do with it. Proper fertility of soil is what gives life to the crops and keeps them going ensuring an enduring agricultural production. The market will steepen the pace of growth in next few years.

 

Get Sample Copy: https://www.polarismarketresearch.com/industry-analysis/complex-fertilizers-market/request-for-sample

 

One of the key factors driving global complex fertilizers market is the rising global population and a consecutive need to see it through ensuring a full-grown harvest. The colossal jump in global population and urban lifestyle and a decline in arable land are putting pressure on the market. Complex fertilizers globally have been divided into product form, product type, crop type and region. Product form is further bifurcated into solid and liquid. The crop segment of complex fertilizers market is classified into cereals and grains, fruits and vegetables and oilseeds among others.

 

Cereals and grains segment dominated and possessed the largest share. On the basis of product type, market includes complete and incomplete complex fertilizers. The incomplete fertilizers held largest share globally.

 

The incomplete fertilizers are suitable for applications in cereals, crops and vegetables and the greenhouse applications making it one of the most employed crop fertilizers all over the world. Asia Pacific held largest market share in complex fertilizers during 2017 and will also prevail upon marketing domain in 2018 to 2026.

 

The fertilizers merge with elements providing nutrients to plants and comprise minerals such as calcium, magnesium and sulphur among others. These nutrients are also known as trace or secondary nutrients. A judicious combination of complex and compound fertilizers offer many advantages like economic savings, convenience in the field and ease in meeting with crop nutrition levels.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/complex-fertilizers-market/request-for-discount-pricing

 

Apart from these growth factors, there are some restraints that includes an inclination towards adoption of organic fertilizers that acts as major restraint for growth. These fertilizers when used with crops provide high nutrition content and for making biofuels which will swing the market in favor of complex fertilizers.

 

Few of the key players mainly focus on innovation and leverage industry insights with investments in R&D and new product launches. The companies hold patent rights which helps to launch further products.

 

Few of the key players include Potash Corporation of Saskachewan, Inc., Israel Chemicals Limited, CF Industries Holdings Inc., The Mosaic Company, Haifa Chemicals Ltd., Yara International ASA and Eurochem Group AG among others.

 

Polaris Market research has segmented the complex fertilizers market on the basis of product type, product form, crop type and region. 

• Product Type Outlook (Revenue USD Billions, 2015 – 2026)
  • Complete Complex Fertilizers
  • Incomplete Complex Fertilizers
• Product Form Outlook (Revenue USD Billions, 2015 – 2026)
  • Solid
  • Liquid
• Crop Outlook (Revenue USD Billions, 2015 – 2026)
  • Cereals and grains
  • Fruits and vegetables
  • Oil seeds

Scaffold Technology Market Analysis, Revenue, Price, Share, Growth Rate, Forecast to 2028

 Global Scaffold Technology Industry: The Latest Research Report to Share Market Insights and Dynamics

The global scaffold technology market  size is expected to reach USD 2.22 billion by 2028 according to a new study by Polaris Market Research. The report “Global Scaffold Technology Market Share, Size, Trends, Industry Analysis Report, By Type (Hydrogels {Wound Healing, 3D Bioprinting, Immunomodulation}, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds); By Application; By Disease Type; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The recent advancements in micro-molding, photo-lithography, and stereo-lithography also driving scaffolding technology. For instance, the innovations in injectable and microporous hydrogels also enabled organ on a chip technology to enhance in-vivo healing. Moreover, ongoing advancements in micro-fabrication technology are also projected to boost the market growth.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/scaffold-technology-market/request-for-sample

 

In 2020, the hydrogels market segment of scaffold technology industry had the largest revenue share. This high share is attributed to the excellent properties of hydrogels, such as controlled drug delivery, and ease of loading drugs. In current times, hydrogels have gained momentum and are regarded as a leading candidate in 3D cell cultures and tissue engineering.

 

The nanofiber scaffolds segment is projected to show the fastest growth rate over the assessment period. Nanoscale fibrous structures with inter-connecting pores facilitate the formation of artificial tissues during the process of tissue engineering. Artificial tissues resemble natural ones, by providing an extracellular matrix of the living tissues.

 

Market participants such as Merck KGaA, Molecular Matrix, Pelobiotech, Corning Incorporated, Avacta Life Sciences Limited, Vericel Corporation, Becton, Dickinson and Company, 3D Biotek LLC, Thermo Fisher Scientific, Xanofi, REPROCELL Inc., Matricel GmbH, Akron Biotech, Nanofiber Solutions, 4titude, 3D BioMatrix, NuVasive, Inc., Allergan, and Medtronic. are some of the key players operating in the global market for scaffold technology.

 

Get Offer :  https://www.polarismarketresearch.com/industry-analysis/scaffold-technology-market/request-for-discount-pricing

 

Players in the marketplace are collaborating with small players to stay competitive in the market for scaffold technology. For instance, in October 2019, Avacta Life Sciences collaboration agreement with ADC Therapeutics to develop Affimer drug conjugates, to use in biological scaffolds.

 

Read More : https://www.prnewswire.com/news-releases/scaffold-technology-market-size-worth-2-22-billion-by-2028--cagr-9-1-polaris-market-research-301243229.html?tc=eml_cleartime

Mining Equipment Market 2021 SWOT Analysis, Top Key Company Profiles and Latest Trends

 Global Mining Equipment Industry: A Latest Research Report to Share Market Insights and Dynamics

The global Mining Equipment Market is anticipated to reach USD 121.4 million by 2026 according to a new research published by Polaris Market Research. In 2017, the surface mining equipment segment dominated the global market, in terms of revenue. In 2017, Asia-Pacific accounted for the majority share in the global mining equipment market.

 

The rapid growth in the demand for metals and minerals majorly drives the growth of this market. Growing usage of resources such as coal and petroleum supports the market growth. The decreasing ore grades further accelerates the adoption of mining equipment. However, high initial investment costs associated with mining equipment, and strict government regulations limit the growth of the market. New emerging markets, and technological advancements would provide growth opportunities for mining equipment market in the coming years.

 

Get Sample Copy @  https://www.polarismarketresearch.com/industry-analysis/mining-equipment-market/request-for-sample
 

Asia-Pacific accounted for the highest share in the global mining equipment market during the forecast period. A significant growth in the emerging economies of China, Japan, India, and Australia among others drives the growth in this region. Increasing demand for petroleum and coal resources in the region, along with rising industrialization in developing countries of this region augment the market growth in the region. Leading global players are expanding their presence in developing nations of India, Indonesia, and Malaysia to tap the growth opportunities offered by these countries.

 

The various applications of mining equipment include metal mining, mineral mining, coal mining, and others. The metal mining equipment segment is expected to lead the mining equipment market during the forecast period owing to increasing demand from emerging economies. The increasing demand for metals such as silver, gold, platinum, and copper for various applications has increased the demand of mining equipment in this application. Use of precious metals such as gold and platinum in jewelry and ornaments has supported the growth of the market.  

 

Click to view the full report TOC, figure and tables @ https://www.polarismarketresearch.com/industry-analysis/mining-equipment-market/request-for-discount-pricing

 

 

The well-known companies profiled in the global mining equipment market report include Komatsu Ltd., Caterpillar Inc., Hitachi Ltd., AB Volvo, Liebherr Group, Caterpillar Inc., Atlas Copco AB, China Coal Technology and Engineering Group Corp., Joy Global Inc., Metso Corporation, Sandvik AB, and Northern Heavy Industries Group Co. Ltd among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Blood Cancer Drugs Market 2021 SWOT Analysis, Top Key Company Profiles and Latest Trends

 Global Blood Cancer Drugs Industry: The Latest Research Report to Share Market Insights and Dynamics

The global blood cancer drugs market is anticipated to reach USD 55.6 billion by 2025 according to a new report published by Polaris Market Research. The report ‘Blood Cancer Drugs Market [By Blood Cancer Type (Leukemia (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia), Lymphoma (Hodgkin Lymphoma, Non-Hodgkin Lymphoma (B-Cell Lymphoma, T-Cell Lymphoma)), and Myeloma; By Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others); By Treatment Approaches (Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic); By Region]: Market Size & Forecast, 2017 – 2025’ provides insights on the current market scenario and the future prospects.

 

The demand for blood cancer drug is primarily driven by growing death incidences by blood cancer, and continuous innovation for developing novel treatments with the help of several ongoing clinical trials. Moreover, increasing research and development of biological and targeted therapies as treatment will spur the blood cancer drugs market during the upcoming period. However, the high price of drugs and the stringent government policies will limit the growth of blood cancer drugs market during the forecast period.

 

Most of the blood cancers start in the bone marrow, where blood is produced. In blood cancer the growth of normal blood cells is dislodged by the uncontrollable growth of abnormal blood cells. These cancerous cells prevent the blood from performing many of its functions. Hence, the existing treatments of blood cancer are being the foundation for developing the new drugs. The steady flow of the blood cancer drugs has created opportunity for research and development in the existing market. For instance, Amgen Inc. received approval for BLINCYTO in July 2017, which is used in treating B-cell precursor Acute Lymphoblastic leukemia. Similarly, European blood cancer drugs market witnessed the approvals of Gazyvaro, by Roche AG that is used in treating advanced follicular lymphoma. Also, novel technologies like CAR-T are likely to be launched this year.

 

Download Sample copy :  https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/request-for-sample

 

The global blood cancer drugs market is segmented into blood cancer type, drugs and treatment approaches. On the basis of blood cancer type, the global blood cancer drugs market is segmented into leukemia, lymphoma and myeloma. The lymphoma segment is expected to drive the majority market of blood cancer drugs followed by leukemia. The global market of this segment is primarily driven by the increasing prevalence of lymphoma, and presence of effective treatments in the market. On the basis of drugs, the global blood cancer drugs market is further categorized into Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others. This continuous innovation for treating various sub-types of blood cancers has led to the development of novel types of treatments. For instance, the combination of Revlimid and Velcade has emerged as the preferential drugs in trials for treating multiple myeloma.

  

On the basis of treatment approaches the global blood cancer drugs market is further segmented into Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic. Due to availability of variety of chemotherapeutic agent in the market chemotherapeutic drugs are expected to hold the higher share in blood cancer drugs market. Moreover, their effectiveness for the treatment of blood cancer and increasing number of cancer patients globally has garnered more demand for chemotherapeutic drugs throughout the world.

 

Geographically, the global blood cancer drugs market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominates the blood cancer drugs market which is followed by Europe and Asia Pacific. Favorable reimbursement policies, surge in R&D investments of various companies, as well as the increase in the number of blood cancer treatments are some of the major factors responsible for the growth of North America’s blood cancer drugs market. Moreover, Asia-Pacific region has been identified as the lucrative market for the for blood cancer drugs due to increasing awareness of the use of these drugs, increased healthcare expenditure, and rising per capita disposable income. These are some of the major factors which are influencing the growth of the blood cancer drugs in Asia-pacific region. 

 

Have Questions? make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/request-for-discount-pricing

 

The leading companies operating in this industry include Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer, Inc., AbbVie Inc., Roche Holding AG., Celgene Corporation, AstraZeneca, Novartis AG, GlaxoSmithKline PLC, Merck & Co., Inc., and Eli Lily & Co. among others.

 

Key Findings from the study suggest blood cancer drugs in the market are much innovative and manufacturers are progressively concentrating on innovation of combination drugs. Companies are in a stage of development of new drugs in order to provide novel treatments for blood cancer. The immunotherapy segment is anticipated to grow at a high growth rate over the forecast period. The growth of this segment is primarily driven by increased awareness for its use as an alternative and effective treatment for blood cancer. North America is presumed to dominate the global blood cancer drugs market over the forecast period. Asia Pacific region which shows signs of high growth potential owing to the booming economies of India, and China.

 

Car T Cell Therapy Market 2021 SWOT Analysis, Top Key Company Profiles and Latest Trends

 The global CAR-T Cell Therapy market size is expected to reach USD 15.4 billion by 2028 growing at a CAGR of 34.2% from 2021 to 2028 according to a new study published by Polaris Market Research. The report “CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen (CD19/CD22, BCMA, Others); By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma (FL), Others); By Regions: Segment Forecast, 2021 – 2028” provides deep dive insights on the current market dynamics and gives a detailed analysis on future growth trends of this market.

 

This market report focuses on CAR-T which is one of the most innovative therapy available in the market which uses the patients’ immune cells to fight cancer. The WBCs (white blood cells) are extracted – reengineered – injected again into the patient body to fight the malignant cells. This novel therapy has joined the bandwagon of the cancer cure treatments and it is expected to be one the sought-after therapies in the market. Majority of the companies have already started investing in them to gain a better market share in this industry.

 

Download Sample Copy: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-sample

 

According to the analysis by Polaris Market Research, the potential of the market is ~ $15 billion by 2028, with major focus on Diffuse Large B-Cell Lymphoma (DLBCL) indication in 2020-21. However, it is expected that the market would also start focusing on Multiple Myeloma (MM) indication and the market for the same is expected to grow at a compounded annual growth rate of more than 46% from 2021 to 2028.

 

It is estimated that U.S. is one of the major markets for CAR-T Cell Therapy due to continuous R&D happening in this region also backed by ongoing regulatory approvals of the new therapies. Along with the new therapy developments, companies are also focusing on establishing centers for cancer awareness and how this novel therapy would help in cancer treatment. This would help the market to grow in this region. The European region is also expected to closely follow by U.S. wherein European Medicine Agencies (EMA) have approved Kymriah and Yescarta which is expected to push the market for further growth in this region. However, the market for Asia Pacific is at its early stages wherein Ministry of Health, Labor and Welfare (MHLW) of Japan is the first regulatory authority to approve Kymriah in APAC.

 

It can be seen that the business scenario of the market is dynamic and major companies are competing with each other to increase their market share in the major geographies of U.S. and Europe. For example, Novartis and Gilead came-up with 33 and 28 authorized centers respectively in U.S. Some of the major companies in this space such as Celgene are expected to file for FDA approvals for two more CAR-Ts lisocabtagene maraleucel in lymphoma and bb2121 (idecabtagene vicleucel) in myeloma.

 

If you have any special requirements, please let us know and we will offer you the report as you want. Place your Quiry Here! https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/speak-to-analyst

 

Along with opening new centers and acquiring necessary government approvals, the companies are also focusing on partnerships, acquisitions and mergers. For instance, Celgene acquired Juno Therapeutics in November 2018 for approximately $9 billion in 2018 and further Bristol-Myers Squibb completed its acquisition of Celgene in November 2019.

 

Some major key players in global CAR-T Cell Therapy Market includes Bluebird Bio (US), Celgene Corporation (US), Gilead Sciences, Inc. (US), Cellectis (France), Servier Laboratories (France), Pfizer Inc. (US), Mereck KGaA (Germany), Amgen Inc. (US), Intellia Therapeutics (US), Novartis International AG (Swiss), Caribou Biosciences, Inc. (US), Celyad (Belgium), Bellicum Pharmaceuticals, Inc. (US), Noile-Immune Biotech (Japan), Nanjing Legend Biotechnology Co., Ltd. (China), Johnson & Johnson (US), Sangamo Therapeutics, Inc. (US) among others.

 

Polaris Market research has segmented the CAR-T Cell Therapy market report on the basis of Target Antigens, Indications, and Region

 

CAR-T Cell Target Antigens Outlook (Revenue, USD Million, 2017 – 2028)

• CD19/CD22
• BCMA (B-Cell Maturation Antigen)
• Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Rα2, LewisY)

CAR-T Cell Indication Outlook (Revenue, USD Million, 2017 – 2028)

• Diffuse Large B-Cell Lymphoma (DLBCL)
• Acute Lymphoblastic Leukemia (ALL)
• Chronic Lymphocytic Leukemia (CLL)
• Multiple Myeloma (MM)
• Follicular Lymphoma (FL)
• Others

CAR-T Cell Regional Outlook (Revenue, USD Million, 2017 – 2028)

• U.S.
• Europe
• Japan
• Rest of the World

Read More : 

https://www.prnewswire.com/news-releases/closed-system-transfer-device-market-size-to-surpass-1-91-billion-by-2028--cagr-20-1-polaris-market-research-301294657.html

https://www.prnewswire.com/news-releases/global-covid-19-vaccine-packaging--delivery-devices-market-size-us-3-58-billion-by-2028--cagr-20-1-pmr-301297573.html

https:/www.prnewswire.com/news-releases/pea-starch-market-size-worth-150-7-million-by-2028--cagr-7-2-polaris-market-research-301306705.html

 

 

 

 

Technical Textiles Market SWOT Analysis, Growth Rate of Top Manufacturers Profiles

 Global Technical Textiles Industry: A Latest Research Report to Share Market Insights and Dynamics

The global technical textiles market is anticipated to reach USD 14.93 billion by 2026 according to a new study published by Polaris Market Research

 

The primary driving factors for the global market includes the increasing consumer profiles along with income levels, rising end user sectors such as automobiles, sports, healthcare etc. The overall industrial and infrastructure development in the emerging and developed nations are yet other potential reasons for the market growth. Moreover, the initiatives from several governments and other regulatory bodies in attracting substantial investments in development of novel technical textile product are also anticipated to drive the industry growth. These products represent mainly a next generation of smart textiles with potential use in various fashion products, technical textiles and furnishing applications. The basic notion of these smart textiles consists of the textile structures that senses and also reacts to various stimuli from the environment. The market expansion of these products is owing to the new textile fiber types and its structure, miniaturization of the electronics and also wireless & wearable technologies.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/technical-textiles-market/request-for-sample

 

The technical textiles include around 51 potential products for high growth that accounted for over 25% of industry size in 2017. A few of these include mulch mats, shade nets, anti-hail, crop covers, anti-bird nets, incontinence diaper, baby diapers, sanitary napkins, surgical disposables, artificial heart valves, bullet proof jackets, disposable bed sheets, nuclear protective clothing, chemical protective clothing, industrial clothing etc. These products represent multi-disciplinary segments with several application sectors. Advancements in functionality of technical fibers and yarns including low elongation at break high tenacity, low thermal shrinkage, high modulus, high resistance to corrosion, higher thermal stability etc. which were the outcome of significant investments in R&D by industry participants have been helpful in increasing its applications in numerous industries.

 

 

Some of the leading industry participants currently operating in the industry include DuPont De Nemours & Co., Royal Ten Cate, Johns Manville, Ahlstrom Corporation, GSE Environmental Inc., Proctor and Gamble, Freudenberg & Co., Hindustan Technical Fabrics Limited, Huesker Synthetic GmbH and 3M.

 

If you have any special requirements, please let us know and we will offer you the report as you want. Place your Quiry Here! https://www.polarismarketresearch.com/industry-analysis/technical-textiles-market/speak-to-analyst

 

North America was the leading regional market in 2017. Along with increasing penetration of these products, consumption of technical textiles is increasing, and several nations cater to their demand by mainly importing these smart textiles from the U.S. The primary export markets of the U.S. include India, Vietnam, Brazil and Taiwan. Taiwan and Korea have emerged as a potentially powerful competitor to the US. The Asia Pacific market is projected to grow at a faster rate compared to other regions.